Gibson, William J.
Nafee, Tarek
Travis, Ryan
Yee, Megan
Kerneis, Mathieu
Ohman, Magnus
Gibson, C. Michael
Clinical trials referenced in this document:
Documents that mention this clinical trial
Machine learning versus traditional risk stratification methods in acute coronary syndrome: a pooled randomized clinical trial analysis
https://doi.org/10.1007/s11239-019-01940-8
Documents that mention this clinical trial
Rationale and design of the Anti-Xa Therapy to Lower cardiovascular events in Addition to standard therapy in Subjects with Acute Coronary Syndrome–Thrombolysis in Myocardial Infarction 51 (ATLAS-ACS 2 TIMI 51) trial: A randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of rivaroxaban in subjects with acute coronary syndrome
https://doi.org/10.1016/j.ahj.2011.01.026
Machine learning versus traditional risk stratification methods in acute coronary syndrome: a pooled randomized clinical trial analysis
https://doi.org/10.1007/s11239-019-01940-8
Documents that mention this clinical trial
A randomized trial to compare the safety of rivaroxaban vs aspirin in addition to either clopidogrel or ticagrelor in acute coronary syndrome: The design of the GEMINI-ACS-1 phase II study
https://doi.org/10.1016/j.ahj.2016.01.004
Machine learning versus traditional risk stratification methods in acute coronary syndrome: a pooled randomized clinical trial analysis
https://doi.org/10.1007/s11239-019-01940-8
Documents that mention this clinical trial
An open-label, randomized, controlled, multicenter study exploring two treatment strategies of rivaroxaban and a dose-adjusted oral vitamin k antagonist treatment strategy in subjects with atrial fibrillation who undergo percutaneous coronary intervention (PIONEER AF-PCI)
https://doi.org/10.1016/j.ahj.2014.12.006
Bleeding associated with the management of acute coronary syndromes
https://doi.org/10.1136/heartjnl-2015-307602
Machine learning versus traditional risk stratification methods in acute coronary syndrome: a pooled randomized clinical trial analysis
https://doi.org/10.1007/s11239-019-01940-8
Funding for this research was provided by:
Janssen Pharmaceuticals Inc.
Article History
First Online: 18 September 2019
Compliance with ethical standards
:
: All authors report research grant support from Janssen Pharmaceuticals Inc.